Developed to Perform. Manufactured to Scale.
Partnering with you across development to commercial manufacturing to bring complex non‑sterile liquids, semi‑solids, and suspensions to market faster.
our partners
01
Pharmaceutical companies
You gain the production flexibility to align batch sizes and volumes with your program needs
02
Biotech Startups
YouYou access the technical expertise required to scale production as your programs advance.
Reach the World.
Our Services
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas facilisis elit sem. Nullam dapibus turpis nunc. Proin interdum nibh et mi volutpat mattis.
Product Development
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreFormulation Development
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreProcess Scale-Up
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreMethod Development
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreMethod Validation
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreAnalytical Capabilities
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreDrug Manufacturing
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreClinical Supply
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn morePrimary & Secondary Packaging
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreLabeling & Serialization
Lorem ipsum dolor sit amet in dubitus veritas consectetur adisciping ellit.
Learn moreYour Competitive Edge
Whether you’re advancing a new molecule or scaling a commercial therapy, our single‑site model ensures seamless scientific, operational, and regulatory support throughout the entire lifecycle.
01
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
02
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
03
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
04
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
05
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
06
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
07
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
08
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
09
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
10
End-to-End Execution
Keep your program within a single GMP facility, streamlining decision-making, minimizing risk, and accelerating your path to market.
Partnerships that last
Many of our clients have partnered with us for more than 20+ years, a testament to the trust, consistency, and collaboration we bring at every stage.
Manufacturing
Biotech company
Manufacturing
Biotech company
Manufacturing
Biotech company
Manufacturing
Biotech company
Manufacturing
Biotech company
Manufacturing
Biotech company
Manufacturing
Biotech company
careers
Join our Team
Work alongside committed professionals and grow your career in an environment that encourages ownership, continuous learning, and long‑term development.
Apply nowNews and
insights
Explore in‑depth resources, practical guidance, and expert analysis to help you navigate complex development, scale‑up, and regulatory challenges.
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Global Regulatory Compliance
Built to exceed global regulatory expectations, our GMP operations embed rigorous compliance at every step, reducing risk, supporting submissions, and strengthening your path to approval.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
Scientific rigor
We do not cut corners. Every formulation, every batch, every test reflects our commitment to pharmaceutical excellence.
CONTACT US
Have a project in
Pipeline?
Let’s discuss how our integrated CDMO expertise can confidently support your program from development through commercialization.
Talk to our expert